ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws in 14-1 Vote

Yesterday, ICER’s independent appraisal committee, the New England Comparative Effectiveness Public Advisory Council (NE-CEPAC) met to discuss the effectiveness and value of Lykos Therapeutics’ MDMA-assisted therapy for PTSD. We have covered ICER’s ongoing appraisal of MDMA-assisted therapy since late March, when the initial draft evidence report was published. As such, we won’t rehash those…

Source